Abstract:Tubular secretion is a primary mechanism along with glomerular filtration for renal elimination of drugs and toxicants into urine. Organic cation transporters (OCTs) and multidrug and toxic extrusion (MATE) transporters facilitate the active secretion of cationic substrates, including drugs such as metformin and endogenous cations. We hypothesized that administration of cimetidine, an Oct/Mate inhibitor, will result in increased plasma levels and decreased renal clearance of metformin and endogenous Oct/Mate substrates in rats. A paired rat pharmacokinetic study was carried out in which metformin (5 mg/kg, intravenous) was administered as an exogenous substrate of Oct/Mate transporters to six Sprague-Dawley rats with and without cimetidine (100 mg/kg, intraperitoneal). When co-administered with cimetidine, metformin area under the curve increased significantly by 3.2-fold, and its renal clearance reduced significantly by 73%. Untargeted metabolomics was performed to investigate the effect of cimetidine on endogenous metabolome in the blood and urine samples. Over 8,000 features (metabolites) were detected in the blood, which were shortlisted using optimized criteria, i.e., a significant increase ( P value < 0.05) in metabolite peak intensity in the cimetidine-treated group, reproducible retention time, and quality of chromatogram peak. The metabolite hits were classified into three groups that can potentially distinguish inhibition of i) extra-renal uptake transport or catabolism, ii) renal Octs, and iii) renal efflux transporters or metabolite formation. The metabolomics approach identified novel putative endogenous substrates of cationic transporters that could be tested as potential biomarkers to predict Oct/Mate transporter mediated drug–drug interactions in the preclinical stages. SIGNIFICANCE STATEMENT Endogenous substrates of renal transporters in animal models could be used as potential biomarkers to predict renal drug-drug interactions in early drug development. Here we demonstrated that cimetidine, an inhibitor of organic cation transporters (Oct/Mate), could alter the pharmacokinetics of metformin and endogenous cationic substrates in rats. Several putative endogenous metabolites of Oct/Mate transporters were identified using metabolomics approach, which could be tested as potential transporter biomarkers to predict renal drug-drug interaction of Oct/Mate substrates.

Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin Via Organic Cation-Selective Transporters

Inhibitory effect of sixteen pharmaceutical excipients on six major organic cation and anion uptake transporters

A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators

Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration.

Influence of permeability enhancers on the paracellular permeability of metformin hydrochloride and furosemide across Caco-2 cells

Inhibition of human efflux transporter ABCC2 (MRP2) by self-emulsifying drug delivery system: influences of concentration and combination of excipients.

Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats

Effects of Commonly Used Excipients on the Expression of CYP3A4 in Colon and Liver Cells

Comparison of in vitro screening methods for evaluating the effects of pharmaceutical excipients on membrane permeability

Development on Oral Intestinal Absorption Mechanism for Metformin Hydrochloride and Its Formulation Optimizations of Gel-Matrix Tablets

Paracellular Pathway Enhancement of Metformin Hydrochloride via Molecular Dispersion in Span 60 Microparticles

Quantitative contributions of hepatic and renal organic cation transporters to the clinical pharmacokinetic cimetidine-metformin interaction

The Use of Organoclays as Excipient for Metformin Delivery: Experimental and Computational Study

Transcellular Transport Behavior of the Intact Polymeric Mixed Micelles with Different Polymeric Ratios

Preparation and Characterization of Intestinal Transporter-Targeted Polymeric Micelles

Studies on Transport Mechanisms of Osthol and Its Preparations in Caco-2 Cell Model

Targeted Disruption of Organic Cation Transporter 3 Attenuates the Pharmacologic Response to Metformin

Organic Cation Transporter and Multidrug and Toxin Extrusion 1 Co-Mediated Interaction Between Metformin and Berberine.

Metformin Transporter Pharmacogenomics: Insights into Drug Disposition—where Are We Now?

Role of Organic Cation Transporter 3 (SLC22A3) and Its Missense Variants in the Pharmacologic Action of Metformin

Effect of Genetic Variation in the Organic Cation Transporter 2 on the Renal Elimination of Metformin